Source: The journal of gene medicine. Unidades: ICB, FM
Subjects: INTERLEUCINA 2 (ANÁLISE), CARCINOMA, NEOPLASIAS RENAIS (SECUNDÁRIO), METÁSTASE NEOPLÁSICA, CULTURA DE CÉLULAS, PROLIFERAÇÃO CELULAR, DIFERENCIAÇÃO CELULAR, MODELOS ANIMAIS, RATOS
ABNT
ROCHA, Flávia Gomes de Góes et al. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma. The journal of gene medicine, v. 13, n. 3, p. 148\2013157, 2011Tradução . . Disponível em: https://doi.org/10.1002/jgm.1547. Acesso em: 30 abr. 2024.APA
Rocha, F. G. de G., Calvo, F. B., Chaves, K. C., Peron, J. P. S., Marques, R. F., Borba, T. R. de, et al. (2011). Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma. The journal of gene medicine, 13( 3), 148\2013157. doi:10.1002/jgm.1547NLM
Rocha FG de G, Calvo FB, Chaves KC, Peron JPS, Marques RF, Borba TR de, Braga MS, Pereira CB, Vicente EJ, Chammas R, Schor N, Bellini MH. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma [Internet]. The journal of gene medicine. 2011 ; 13( 3): 148\2013157.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1002/jgm.1547Vancouver
Rocha FG de G, Calvo FB, Chaves KC, Peron JPS, Marques RF, Borba TR de, Braga MS, Pereira CB, Vicente EJ, Chammas R, Schor N, Bellini MH. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma [Internet]. The journal of gene medicine. 2011 ; 13( 3): 148\2013157.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1002/jgm.1547